登录

首页 > 资讯动态

FDA批准治疗晚期尿路上皮癌的新疗法 2019.12.18

FDA approves new type of therapy to treat advanced urothelial cancer Today, the U.S. Food and Drug Administration granted accelerated approval to Padcev (enfortumab vedotin-ejfv), a Nectin-4-directed antibody and microtubule inhibitor conjugate, mea...